GlassScriptPhysician profile
Abdi A Jama
NPI 1659382422
$9,822.15
in general payments reported to CMS, 2019-2025
13 companies · $5,438 in 2025
The $5,438 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $98.71 · 2021: $254 · 2022: $730 · 2023: $1,566 · 2024: $1,370 · 2025: $5,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,609 · Food and Beverage: $2,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,609.48 |
| Food and Beverage | $2,764.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,994.35 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abbott Laboratories | $2,965.93 | 2021-2025 | Perclose Prostyle, Supera, Mitraclip |
| Biosense Webster, INC. | $1,227.83 | 2025 | Carto 3 |
| Boston Scientific Corporation | $725.02 | 2020-2025 | Avvigo Guidance System, General - Therapies |
| Edwards Lifesciences Corporation | $667.43 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medical Device Business Services, INC. | $634.97 | 2024 | Carto 3 |
| Medtronic Vascular, INC. | $241.79 | 2019-2020 | |
| Abiomed | $134.79 | 2019 | |
| Shockwave Medical, INC | $105.95 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Recor Medical INC | $63.42 | 2025 | Paradise Ultrasound Renal Denervation System |
| Angiodynamics, INC. | $24.38 | 2021 | |
| Philips North America LLC | $24.31 | 2024 | (6574) Coronary Other |
| Chiesi USA, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdi Jama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.